Company intelligence / Profile preview
Veloxis Pharmaceuticals
Cary, North Carolina, USAveloxis.com ↗
- Ownership
- Private
- Employees
- ~128
- Development stage
- Commercial
01
Overview
Veloxis has successfully commercialized ENVARSUS XR/LCP-Tacro, a once-daily extended-release tacrolimus tablet that has demonstrated non-inferiority to standard twice-daily tacrolimus in preventing organ rejection post-kidney transplantation. The company leverages its proprietary MeltDose® technology to improve oral bioavailability and patient outcomes. Additional programs include VEL101 in early clinical development and outlicensed cardiovascular products such as AtorFen. The company was acquired by Asahi Kasei Corporation in March 2020 but continues to operate under its own brand with a focus on expanding its transplant and specialty pharma portfolio.[4][1][3]
- Therapeutic areas
- OncologyImmunologyCardiovascular
- Modalities
- Small molecules (e.g., tacrolimus, fenofibrate, atorvastatin combinations)[6][8]
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Athena Drug Delivery Solutions—exclusive rights to develop/commercialize AtorFen in certain territories.[8]Outlicensing partnerships for Fenoglide.
Beyond the preview
Go deeper on Veloxis Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Veloxis Pharmaceuticals.